Dr. Julie Louise Gerberding is the CEO of the Foundation for the National Institutes of Health, a non-profit organization that builds public-private research partnerships to support the mission of the NIH. She co-chairs the CSIS Commission on Strengthening America's Health Security and is a member of the Commonwealth Fund Commission on a National Public Health System. Previously, she served as President of the vaccines business and as Executive Vice President and the Chief Patient Officer at Merck & Co., Inc. From 2003-2009, Dr. Gerberding led the U.S. Centers for Disease Control and Prevention (CDC). She serves on the boards of HilleVax, Mayo Clinic, National Health Council, and Case Western Reserve University. Dr. Gerberding is a member of the National Academy of Medicine and the adjunct faculties of the University of California, San Francisco, and Case Western Reserve University.
History of Employment
Position
Division
Organization
Start
End
Chief Executive Officer
Foundation for the National Institutes of Health
2022
Present
Chief Patient Officer
Population Health and Sustainability
Merck
2021
2022
Executive Vice President
Strategic Communications, Global Public Policy, and Population Health
Merck & Co., Inc.
2014
2016
President
Merck Vaccines
2010
2014
Director
Centers for Disease Control and Prevention
2002
2009
Administrator
Agency for Toxic Substances and Disease Registry
Acting Deputy Director
National Center for Infectious Diseases
Centers for Disease Control and Prevention
Director
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention
Director
Prevention Epicenter
Centers for Disease Control and Prevention
Associate Professor of Medicine
University of California, San Francisco
Associate Clinical Professor of Medicine
Emory University
Consultant to various governmental and non-governmental organizations
Primary Sector of Expertise
--